MARKET FORECAST FOR NK-CELL LYMPHOMA DRUGS AND THERAPIES

NK-Cell Lymphoma Therapeutics Market Outlook NK-cell lymphoma is a rare and aggressive cancer that originates in natural killer (NK) cells—immune system components responsible for targeting infected or malignant cells. The most prevalent subtype, extranodal NK/T-cell lymphoma, nasal type (ENKL), primarily affects the nasal region but can also in